Developer docs
API playgroundTry for free, no card

Search company profiles

viO HealthTech

Full company profile

uuid0002a3l

Namestring
viO HealthTech
Legal namestring
viO HealthTech
Websiteurl
viohealthtech.com
Company typeenum
Private
Founded yearint
2006
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOld Saybrook, United States
HQ citystring
Old Saybrook
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cycle tracking software, ovulation prediction algorithms, women's health technology, fertility tracking wearables, reproductive health monitoring
Industry4 codes
1Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices)
CodeCRACAQAJPrimaryYes
2Consumer Health Wearables & Fitness Trackers (Wellness Monitoring)
CodeHLAHACAJPrimaryNo
3Health Monitoring Wearables (ECG, BP, SpO2, CGM-compatible)
CodeCRACAIAFPrimaryNo
4Contraception & Family Planning Telehealth (birth control, counseling, follow-up)
CodeHLALAHABPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Measuring & Controlling Devices, Nec3829
Product category
Women's Health Technology
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Technology Licensing/Acquisition
TypeLicensing Royalties
Description

viO HealthTech's core technology (cycle and ovulation tracking algorithms) was acquired by Ultrahuman Healthcare Private Limited in August 2025. Prior to acquisition, the company generated revenue through its health tracking technology, likely via app subscriptions or B2B licensing to wearables manufacturers.

athletechnews.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components2 values
Technology or R&D, Personnel
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

viO HealthTech developed proprietary cycle and ovulation tracking algorithms for integration into wearable devices, enabling real-time women's health monitoring. The company's technology was acquired by Ultrahuman Healthcare Private Limited in August 2025 and integrated into the Ultrahuman Ring AIR device for cycle monitoring, ovulation prediction, and fertility awareness.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

viO HealthTech was a women's health technology company specializing in menstrual cycle and ovulation tracking algorithms. The company operated as a focused product before being acquired by Ultrahuman Healthcare Private Limited in August 2025. The core offering consisted of proprietary cycle prediction algorithms that were designed for integration into wearable health devices, specifically targeting the smart ring form factor.

Product and service1 record
1viO HealthTech Cycle and Ovulation Tracking Algorithms
CategoryWomen's Health Software
Description

Proprietary algorithms for menstrual cycle and ovulation prediction, designed to be integrated into wearable devices for women's health tracking. Targeted at wearable device manufacturers seeking to embed accurate women's health capabilities into their products.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Ultrahuman Healthcare Private Limited
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-08-01
Description

Ultrahuman Healthcare Private Limited acquired viO HealthTech in August 2025 to integrate viO HealthTech's proprietary cycle and ovulation tracking algorithms into the Ultrahuman Ring AIR device. This acquisition enables Ultrahuman to offer comprehensive women's health tracking features including cycle monitoring, ovulation prediction, and fertility awareness within their wearable health ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Ultrahuman Healthcare Private Limited
TypeBroad incumbent
Description

Acquirer and parent company; distributes viO's algorithms via its Ring AIR/PRO. Directly comparable as a smart ring + women's health wearable platform with global e-commerce and app distribution.

2Oura
TypeDirect peer
Description

Smart ring with cycle and fertility insights; the most direct form-factor competitor to the Ultrahuman Ring AIR/PRO platform that hosts viO's algorithms.

3Natural Cycles
TypeDirect peer
Description

FDA-cleared fertility/contraception app that uses temperature and cycle data. Comparable as a dedicated cycle and ovulation prediction consumer product, though app-only vs. viO's wearable-embedded model.

4Clue
TypeDirect peer
Description

Leading period and ovulation tracking app; Ultrahuman already has a co-marketing partnership with Clue. Directly comparable as a cycle/fertility awareness platform competing for the same end user.

5Ava
TypeDirect peer
Description

Wearable fertility tracking bracelet for cycle and pregnancy detection. Directly comparable as a hardware-based women's reproductive health monitoring product.

6Apple (Health / Apple Watch)
TypeBroad incumbent
Description

Apple Watch and iPhone Health app offer cycle tracking and fertility windows via predictive algorithms. Comparable as a large incumbent platform with native cycle tracking on a consumer wearable.

7Fitbit (Google)
TypeBroad incumbent
Description

Health wearable with menstrual health tracking features, now part of Google. Comparable as a major platform player in the consumer health wearables space with cycle/fertility features.

8Garmin
TypeBroad incumbent
Description

Smartwatches and fitness wearables with menstrual cycle and pregnancy tracking. Comparable as a long-established wearable incumbent with women's health features in its product portfolio.

9Tempdrop
TypeEmerging player
Description

Wearable basal body temperature sensor for fertility tracking. Comparable as a focused women's health wearable that uses overnight physiological data for cycle and ovulation prediction.

10Elvie
TypeEmerging player
Description

Women's health technology company (pelvic floor, breast pump) with a connected app. Comparable as a digital women's health brand expanding into connected reproductive health hardware and software.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

viO HealthTech

Women's Health Technologyviohealthtech.com

viO HealthTech firmographics

Firmographics
Name
viO HealthTech
Legal name
viO HealthTech
Website
https://viohealthtech.com
Company type
Private
Founded year
2006
Operating status
Acquired
Headcount range
11–50 employees
Ownership category
akta.pro rank

viO HealthTech industry classification

Industry
Product category
Women's Health Technology
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Measuring & Controlling Devices, Nec (3829)
akta.pro primary industry
Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices) (CRACAQAJ)
akta.pro secondary industries
Consumer Health Wearables & Fitness Trackers (Wellness Monitoring) (HLAHACAJ), Health Monitoring Wearables (ECG, BP, SpO2, CGM-compatible) (CRACAIAF), Contraception & Family Planning Telehealth (birth control, counseling, follow-up) (HLALAHAB)

Keywords

  • Cycle tracking software
  • Ovulation prediction algorithms
  • Women's health technology
  • Fertility tracking wearables
  • Reproductive health monitoring

Where viO HealthTech is headquartered

Location

Headquarters

HQ city
Old Saybrook
HQ country
United States
HQ region
North America

Markets served

viO HealthTech business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel

Revenue model

  1. Technology Licensing/Acquisition: viO HealthTech's core technology (cycle and ovulation tracking algorithms) was acquired by Ultrahuman Healthcare Private Limited in August 2025. Prior to acquisition, the company generated revenue through its health tracking technology, likely via app subscriptions or B2B licensing to wearables manufacturers.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

viO HealthTech product offering

Product offering

Core offering

viO HealthTech developed proprietary cycle and ovulation tracking algorithms for integration into wearable devices, enabling real-time women's health monitoring. The company's technology was acquired by Ultrahuman Healthcare Private Limited in August 2025 and integrated into the Ultrahuman Ring AIR device for cycle monitoring, ovulation prediction, and fertility awareness.

Product overview

viO HealthTech was a women's health technology company specializing in menstrual cycle and ovulation tracking algorithms. The company operated as a focused product before being acquired by Ultrahuman Healthcare Private Limited in August 2025. The core offering consisted of proprietary cycle prediction algorithms that were designed for integration into wearable health devices, specifically targeting the smart ring form factor.

Differentiator

Problem solved

Functional benefit

Products and services

  • viO HealthTech Cycle and Ovulation Tracking Algorithms Proprietary algorithms for menstrual cycle and ovulation prediction, designed to be integrated into wearable devices for women's health tracking. Targeted at wearable device manufacturers seeking to embed accurate women's health capabilities into their products.

Companies that use viO HealthTech

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

viO HealthTech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature1 record

viO HealthTech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Ultrahuman Healthcare Private LimitedcoreOEM/ Whitelabel/ Licensing Partner · 1 August 2025Ultrahuman Healthcare Private Limited acquired viO HealthTech in August 2025 to integrate viO HealthTech's proprietary cycle and ovulation tracking algorithms into the Ultrahuman Ring AIR device. This acquisition enables Ultrahuman to offer comprehensive women's health tracking features including cycle monitoring, ovulation prediction, and fertility awareness within their wearable health ecosystem.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

viO HealthTech competitors and assessment

Company assessment

Broad incumbents

  • Ultrahuman Healthcare Private Limited: Acquirer and parent company; distributes viO's algorithms via its Ring AIR/PRO. Directly comparable as a smart ring + women's health wearable platform with global e-commerce and app distribution.
  • Apple (Health / Apple Watch): Apple Watch and iPhone Health app offer cycle tracking and fertility windows via predictive algorithms. Comparable as a large incumbent platform with native cycle tracking on a consumer wearable.
  • Fitbit (Google): Health wearable with menstrual health tracking features, now part of Google. Comparable as a major platform player in the consumer health wearables space with cycle/fertility features.
  • Garmin: Smartwatches and fitness wearables with menstrual cycle and pregnancy tracking. Comparable as a long-established wearable incumbent with women's health features in its product portfolio.

Direct peers

  • Oura: Smart ring with cycle and fertility insights; the most direct form-factor competitor to the Ultrahuman Ring AIR/PRO platform that hosts viO's algorithms.
  • Natural Cycles: FDA-cleared fertility/contraception app that uses temperature and cycle data. Comparable as a dedicated cycle and ovulation prediction consumer product, though app-only vs. viO's wearable-embedded model.
  • Clue: Leading period and ovulation tracking app; Ultrahuman already has a co-marketing partnership with Clue. Directly comparable as a cycle/fertility awareness platform competing for the same end user.
  • Ava: Wearable fertility tracking bracelet for cycle and pregnancy detection. Directly comparable as a hardware-based women's reproductive health monitoring product.

Emerging players

  • Tempdrop: Wearable basal body temperature sensor for fertility tracking. Comparable as a focused women's health wearable that uses overnight physiological data for cycle and ovulation prediction.
  • Elvie: Women's health technology company (pelvic floor, breast pump) with a connected app. Comparable as a digital women's health brand expanding into connected reproductive health hardware and software.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

viO HealthTech social profiles

Digital presence

viO HealthTech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

viO HealthTech leadership team

Management profile

Number of profiles

Profiles2 records

viO HealthTech funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

viO HealthTech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about viO HealthTech

What does viO HealthTech do?

viO HealthTech developed proprietary cycle and ovulation tracking algorithms for integration into wearable devices, enabling real-time women's health monitoring. The company's technology was acquired by Ultrahuman Healthcare Private Limited in August 2025 and integrated into the Ultrahuman Ring AIR device for cycle monitoring, ovulation prediction, and fertility awareness.

Is viO HealthTech a public or private company?

viO HealthTech is a private company. It is classified as corporate owned and is currently acquired.

When was viO HealthTech founded?

viO HealthTech was founded in 2006. It employs 11 to 50 people.

Where is viO HealthTech based?

viO HealthTech is headquartered in Old Saybrook, United States, in the North America region.

How does viO HealthTech make money?

One revenue line is on record: technology Licensing/Acquisition.

Who are viO HealthTech's main competitors?

Broad incumbents on record are Ultrahuman Healthcare Private Limited, Apple (Health / Apple Watch), Fitbit (Google) and Garmin. Direct peers are Oura, Natural Cycles, Clue and Ava. Emerging players are Tempdrop and Elvie.

Does viO HealthTech have an API?

No public API is recorded for viO HealthTech.

What industry is viO HealthTech in?

viO HealthTech's product category is Women's Health Technology. Its primary akta.pro industry code is CRACAQAJ, Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices), with a secondary code of HLAHACAJ, Consumer Health Wearables & Fitness Trackers (Wellness Monitoring). Its NAICS code is 334510 and its SIC code is 3829.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comFuture Perspectives: Key Trends Shaping the Menstrual Health Apps Market Until 2030The menstrual health apps market is projected to reach $4.65 billion by 2030, growing at a compound annual growth rate of 18.9%, driven by telehealth integration, wearable technology adoption, and personalized digital wellness platforms. A notable acquisition occurred in August 2025 when Ultrahuman Healthcare Private Limited acquired Fertility Focus Limited to integrate viO HealthTech's cycle and ovulation tracking algorithms into the Ultrahuman Ring AIR device. Key trends shaping the market include AI-powered cycle predictions, cloud-based data storage with cybersecurity measures, and real-time health monitoring through IoT wearables.UltrahumanIntroducing Cycle & Ovulation Pro: Best-in class ovulation tracking for all cyclesUltrahuman announced its acquisition of viO HealthTech and the simultaneous launch of Cycle & Ovulation Pro for the Ultrahuman Ring AIR smart ring. The new feature, rolling out now in the USA, UK, EU, Australia, and Canada, offers over 90% accuracy for ovulation confirmation by adapting OvuSense™ technology originally developed over 15 years with data from 260,000 cycles. The product is specifically designed for women with diverse cycle patterns including PCOS, endometriosis, or thyroid disorders, marking a strategic expansion of Ultrahuman's women's health tracking capabilities into the consumer wellness market.TechCrunchUltrahuman acquires viO HealthTech to launch enhanced cycle and ovulation trackingUltrahuman acquired women's health company viO HealthTech to launch Cycle and Ovulation Pro, a plug-in for its Ultrahuman Ring AIR. The plug-in uses a temperature-sensing algorithm trained on over 260,000 cycles and costs $3.99 per month or $39.99 per year. It is available starting Friday in the U.S., U.K., EU, Australia, and Canada.YahooUltrahuman acquires viO HealthTech to launch enhanced cycle and ovulation trackingUltrahuman acquired viO HealthTech to launch Cycle and Ovulation Pro, a plug-in for its Ultrahuman Ring AIR. The plug-in uses a temperature-sensing algorithm trained on over 260,000 cycles and costs $3.99 per month or $39.99 per year. It is available starting Friday in the U.S., U.K., EU, Australia, and Canada.PR NewswireviO HealthTech Broadens Fertility Offerings to Provide Digital Solutions for the Complete Women's Health JourneyFertility Focus has rebranded as viO HealthTech to expand its digital therapeutics offerings from fertility monitoring to broader women's health management. The company plans to utilize its OvuSense technology and clinical data to address conditions such as PCOS, endometriosis, and menopause through new app-based solutions.PR NewswireFertility Focus Presents New Data That Supports Clinical Screening Ability of OvuSense Pro at ASRM 2020 Annual MeetingFertility Focus presented new research at the ASRM Virtual Scientific Congress & Expo (October 17-21, 2020) showing that analysis of 20,067 ovulatory cycles from 8,177 OvuSense users confirms links between specific continuous Core Body Temperature (cCBT) patterns and causes of infertility and miscarriage risk. The study confirms atypical cCBT patterns can help screen for conditions such as Polycystic Ovarian Syndrome (PCOS) and Diminished Ovarian Reserve (DOR), and supports the clinical screening capability of OvuSense Pro, the company's remote monitoring platform launched based on this research. The findings indicate that around 30% of women with PCOS have regular cycles and may go undiagnosed, highlighting the potential value of such screening methods for clinicians working with couples struggling to conceive.